Partner Content Partner Content Immuno-Oncology challenges include identifying patients befo... Challenges facing Immuno-Oncology industry
News EU regulators reject new use for Opdivo, as Keytruda edges a... Keytruda begins to win battle of the immunotherapies
News Lung cancer drug Keytruda to become routinely available on N... NICE has given the green light for lung cancer drug Keytruda to be used as a routine treatment for certain patients in England.
Events Partner Content Rational Combinations 360 Addressing key aspects across all facets of combination
News FDA knocks back Pharming's bid for wider Joenja use The FDA has turned down Pharming's bid to broaden the label of Joenja for rare immunodeficiency disorder APDS so it can be used in younger patients.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
